Agile Therapeutics: Debating My Position [Seeking Alpha]
Agile Therapeutics, Inc. (AGRX)
Last agile therapeutics, inc. earnings: 5/2 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.agiletherapeutics.com/investor-relations
Company Research
Source: Seeking Alpha
Agile Therapeutics: Debating My Position Summary Agile Therapeutics recently resubmitted their NDA for Twirla and got an acceptance notification only a few days later. Twirla's PDUFA date is scheduled for November 16th. The FDA has yet to schedule an AdCom for Twirla, which has me debating how I should manage my AGRX position. I explain why this is a major development. AGRX has continued to trade on technicals since the beginning of the year. However, the recent news has the hallmarks of a "sell the news" event. Finally, I provide my game plan for AGRX for the summer as we wait for the PDUFA or a potential AdCom. Agile Therapeutics ( publicized The resubmitted NDA is comprised stated In my previous articles, I have covered AGRX's return from a sub-$1 stock and how the stock is due for a resurgence over the course of 2019. Since my first article No AdCom The FDA accepted Agile’s NDA resubmission but did not schedule an AdCom for the twice CRL’d Twirla. Although some might see this as a
Show less
Read more
Impact Snapshot
Event Time:
AGRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGRX alerts
High impacting Agile Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AGRX
News
- Agile Therapeutics Announces Delisting from Nasdaq [Yahoo! Finance]Yahoo! Finance
- Agile Therapeutics Announces Delisting from NasdaqGlobeNewswire
- Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024GlobeNewswire
- Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024GlobeNewswire
- Agile Therapeutics, Inc. (NASDAQ: AGRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
AGRX
Earnings
- 11/9/23 - Beat
AGRX
Sec Filings
- 3/28/24 - Form 8-K
- 3/25/24 - Form 8-K
- 3/14/24 - Form 8-K
- AGRX's page on the SEC website